Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR4 | P31391 | 5/20 | 0.54 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 4/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.37 |
| ▸ | TP53 | P04637 | 3/20 | 0.37 |
| ▸ | RECQL | P46063 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17754876 | 0.76 | SSTR4 (0.48) | SSTR4HDAC8MAPTKDM4ETP53 | |
| SCHEMBL22015341 | 0.76 | SSTR4 (0.53) | SSTR4MAPTKDM4ETP53RECQL | |
| SCHEMBL22015391 | 0.75 | SSTR4 (0.51) | SSTR4MAPTKDM4ERECQLNPSR1 | |
| SCHEMBL22015379 | 0.75 | SSTR4 (0.54) | SSTR4 | |
| SCHEMBL5632902 | 0.71 | MAPT (0.47) | SSTR4HDAC8MAPTKDM4ETP53 | |
| SCHEMBL1580083 | 0.71 | MAPT (0.54) | HDAC8MAPTKDM4ETP53RECQL | |
| SCHEMBL19724571 | 0.70 | SSTR4 (1.00) | SSTR4 | |
| SCHEMBL16255852 | 0.70 | SSTR4 (1.00) | SSTR4 | |
| SCHEMBL22015969 | 0.69 | SSTR4 (0.54) | SSTR4MAPTKDM4ERECQLNPSR1 | |
| SCHEMBL19724460 | 0.69 | SSTR4 (0.69) | SSTR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3218372-B1 | MORPHOLINE AND 1,4-OXAZEPANE AMIDES AS SOMATOSTATIN RECEPTOR SUBTYPE 4 (SSTR4) AGONISTS | BOEHRINGER INGELHEIM INT (DE) | 2020-05-20 | — | — | EP | disclosed |